Quick Answer
Astera Labs, Inc. reported Cash and Equivalents of $167.61 million for fiscal year 2025.
Astera Labs, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $167.61M | +110.7% |
| 2024 | $79.55M | +76.4% |
| 2023 | $45.10M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $140.41M | +11.3% | -13.5% |
| June 30, 2025 | $162.33M | -61.4% | +87.8% |
| March 31, 2025 | $86.43M | -87.6% | +8.6% |
| December 31, 2024 | $79.55M | +76.4% | -36.9% |
| September 30, 2024 | $126.12M | — | -70.0% |
| June 30, 2024 | $421.08M | — | -39.5% |
| March 31, 2024 | $696.08M | — | +1443.5% |
| December 31, 2023 | $45.10M | — | — |
- Astera Labs, Inc. showed an increase of +110.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2023–2025 period, Astera Labs, Inc.’s cash and equivalents has grown by 271.7% (from $45.10 million to $167.61 million).
- The most recent figure is from Astera Labs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: